Creating More Accurate Measurements of NSCLC Treatment Response
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read MorePosted by Steve Halasey | Nov 12, 2018 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics |
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read MorePosted by Steve Halasey | Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics |
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Standards |
The cell line-derived myeloid cancer reference standard contains 22 mutations across 19 oncology-relevant genes.
Read MorePosted by Melissa Mayer | Aug 30, 2018 | Prenatal Testing, Software |
This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read MorePosted by Melissa Mayer | Aug 6, 2018 | Leukemia, Software |
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read More